Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,449 | 77 | 62.8% |
| Travel and Lodging | $1,450 | 4 | 37.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Abbott Laboratories | $3,410 | 68 | $0 (2024) |
| Medtronic USA, Inc. | $211.64 | 3 | $0 (2020) |
| Nevro Corp. | $111.09 | 1 | $0 (2017) |
| SI-BONE, INC. | $44.62 | 1 | $0 (2024) |
| Biohaven Pharmaceuticals, Inc. | $38.77 | 2 | $0 (2021) |
| Collegium Pharmaceutical, Inc. | $30.95 | 2 | $0 (2020) |
| Averitas Pharma Inc. | $16.41 | 1 | $0 (2023) |
| Curonix LLC | $15.40 | 1 | $0 (2024) |
| PFIZER INC. | $12.10 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $240.47 | 5 | Abbott Laboratories ($180.45) |
| 2023 | $293.89 | 9 | Abbott Laboratories ($277.48) |
| 2022 | $480.54 | 16 | Abbott Laboratories ($480.54) |
| 2021 | $264.51 | 10 | Abbott Laboratories ($218.57) |
| 2020 | $1,982 | 26 | Abbott Laboratories ($1,792) |
| 2019 | $348.12 | 12 | Abbott Laboratories ($320.55) |
| 2018 | $140.36 | 1 | Abbott Laboratories ($140.36) |
| 2017 | $148.56 | 2 | Nevro Corp. ($111.09) |
All Payment Transactions
81 individual payment records from CMS Open Payments — Page 3 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/08/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Travel and Lodging | In-kind items and services | $562.60 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/08/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Travel and Lodging | In-kind items and services | $57.37 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/08/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/08/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/08/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/07/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $120.17 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/07/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Travel and Lodging | In-kind items and services | $44.47 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/07/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $10.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/07/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $7.00 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/07/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $3.50 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/06/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $152.33 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/05/2020 | Medtronic USA, Inc. | INTELLIS (Device) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 02/03/2020 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $12.30 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/13/2020 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.48 | General |
| Category: Opioid Analgesic | ||||||
| 01/06/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/06/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/06/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $30.78 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/06/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $16.04 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/03/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $63.64 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 12/03/2019 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $11.67 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/27/2019 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 11/25/2019 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $15.47 | General |
| Category: Opioid Analgesic | ||||||
| 10/14/2019 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $8.09 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 10/09/2019 | PFIZER INC. | LYRICA (Drug), FLECTOR PATCH | Food and Beverage | In-kind items and services | $12.10 | General |
| Category: NEUROSCIENCE;PAIN | ||||||
| 09/16/2019 | Abbott Laboratories | Octrode SCS Leads (Device) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 2,932 | 9,422 | $1.9M | $339,586 |
| 2022 | 33 | 3,398 | 11,198 | $2.2M | $428,945 |
| 2021 | 33 | 3,006 | 8,269 | $2.0M | $420,961 |
| 2020 | 24 | 1,851 | 5,785 | $1.2M | $280,247 |
All Medicare Procedures & Services
122 procedure records from CMS Medicare Utilization — Page 3 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 47 | 47 | $10,152 | $3,622 | 35.7% |
| 64490 | Injection of upper or middle spine facet joint using imaging guidance, single level | Office | 2022 | 13 | 25 | $17,500 | $3,460 | 19.8% |
| 64634 | Destruction of upper or middle spinal facet joint nerves using imaging guidance, each additional facet joint | Office | 2022 | 12 | 13 | $8,970 | $2,554 | 28.5% |
| 64454 | Injection of anesthetic agent and/or steroid into knee nerve branch using imaging guidance | Office | 2022 | 12 | 13 | $9,750 | $2,088 | 21.4% |
| 64484 | Injection of anesthetic and/or steroid drug into sacral spine nerve root using imaging guidance, each additional level | Office | 2022 | 18 | 24 | $7,008 | $2,052 | 29.3% |
| 64491 | Injection of upper or middle spine facet joint using imaging guidance, second level | Office | 2022 | 12 | 23 | $11,500 | $1,674 | 14.6% |
| 95972 | Electronic analysis of implanted neurostimulator generator with complex spinal cord or peripheral nerve stimulator programming | Office | 2022 | 27 | 42 | $9,912 | $1,644 | 16.6% |
| 20552 | Injection of trigger points, 1-2 muscles | Office | 2022 | 21 | 29 | $6,525 | $1,059 | 16.2% |
| 64405 | Injection of anesthetic agent and/or steroid into upper neck and back of head nerve | Office | 2022 | 14 | 17 | $6,800 | $990.05 | 14.6% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 69 | 79 | $2,469 | $693.50 | 28.1% |
| J1030 | Injection, methylprednisolone acetate, 40 mg | Office | 2022 | 85 | 108 | $1,080 | $547.68 | 50.7% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2022 | 292 | 4,849 | $24,245 | $461.92 | 1.9% |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 2022 | 244 | 552 | $10,350 | $145.35 | 1.4% |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | Office | 2022 | 374 | 1,241 | $7,757 | $142.48 | 1.8% |
| J0690 | Injection, cefazolin sodium, 500 mg | Office | 2022 | 14 | 23 | $230.00 | $15.48 | 6.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 395 | 1,186 | $395,231 | $77,620 | 19.6% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 216 | 482 | $465,200 | $74,935 | 16.1% |
| 62323 | Injection of substance into spinal canal of lower back or sacrum using imaging guidance | Office | 2021 | 172 | 289 | $308,218 | $57,223 | 18.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2021 | 252 | 656 | $129,680 | $40,125 | 30.9% |
| 99152 | Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 15 minutes | Office | 2021 | 340 | 698 | $168,754 | $26,663 | 15.8% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2021 | 68 | 174 | $55,680 | $19,224 | 34.5% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance, single level | Office | 2021 | 62 | 86 | $68,800 | $17,489 | 25.4% |
| 64635 | Destruction of lower or sacral spinal facet joint nerves using imaging guidance | Office | 2021 | 34 | 51 | $55,233 | $16,428 | 29.7% |
| 62321 | Injection of substance into spinal canal of upper or middle back using imaging guidance | Office | 2021 | 49 | 69 | $67,551 | $13,327 | 19.7% |
| 63650 | Implantation of spinal neurostimulator electrodes, accessed through the skin | Office | 2021 | 11 | 18 | $16,146 | $13,081 | 81.0% |
About Dr. Matthew Drakeley, M.D
Dr. Matthew Drakeley, M.D is a Pain Medicine healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/02/2014. The National Provider Identifier (NPI) number assigned to this provider is 1962820373.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Matthew Drakeley, M.D has received a total of $3,898 in payments from pharmaceutical and medical device companies, with $240.47 received in 2024. These payments were reported across 81 transactions from 10 companies. The most common payment nature is "Food and Beverage" ($2,449).
As a Medicare-enrolled provider, Drakeley has provided services to 11,187 Medicare beneficiaries, totaling 34,674 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 122 distinct procedure/service records.
Practice Information
- Specialty Pain Medicine
- Location Coraopolis, PA
- Active Since 04/02/2014
- Last Updated 09/19/2025
- Taxonomy Code 2081P2900X
- Entity Type Individual
- NPI Number 1962820373
Products in Payments
- Proclaim Family of SCS IPGs (Device) $2,023
- PROCLAIM (Device) $457.37
- ETERNA (Device) $314.56
- Proclaim IPG (Device) $209.90
- INTELLIS (Device) $174.17
- Axium Sheath Braided DRG (Device) $140.36
- Senza Spinal Cord Stimulation System (Device) $111.09
- Octrode SCS Leads (Device) $98.31
- OCTRODE (Device) $77.20
- AXIUM (Device) $53.26
- NURTEC ODT (Drug) $38.77
- RESTORE (Device) $37.47
- PRODIGY (Device) $36.08
- XTAMPZA (Drug) $30.95
- QUTENZA (Drug) $16.41
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $15.40
- LYRICA (Drug) $12.10
- NALOCET (Drug) $7.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.